STO · BRAIN.ST
BrainCool AB (publ)
SEK 1.03-SEK 0.04 (-3.37%)
BrainCool AB (publ)’s quoted price sits in the upper half of its reported 52-week range, 10.26% below the high.
Loading market information…
STO · ARCOMA.ST · SEK
Stock price, earnings
Quote as of Oct 29, 2026, 03:55 PM UTC. Cached market data; not a live quote.
One-year closing-price history · SEK. Historical prices are not a forecast.
Arcoma AB’s quoted price sits in the lower half of its reported 52-week range, 20.4% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Arcoma AB’s next earnings report is currently expected on Feb 18, 2027, with estimated earnings per share of SEK 0.18. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Arcoma AB’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Arcoma AB is a global provider that designs, manufactures, and supplies cutting-edge radiology solutions. Their product line features advanced digital x-ray and radiography systems. These versatile systems are suitable for a wide array of radiographic applications and are utilized across various clinical environments, including general practice, musculoskeletal, thoracic, pediatric, and trauma/resuscitation units. The company distributes its products through a network of OEM partners. Arcoma AB was founded in 1990 and is headquartered in Växjö, Sweden.
Latest available per-share figures in SEK. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 06:28 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
| Q2 2025 | Aug 21, 2025 | SEK 0.00-99.7% vs estimate | SEK 31.38M-15.19% vs estimate |
|---|
| Q1 2025 | Apr 29, 2025 | SEK 0.16-22.5% vs estimate | SEK 34.88M-20.74% vs estimate |
|---|
| Q4 2024 | Feb 13, 2025 | SEK 0.10 | SEK 37.00M |
|---|
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
SEK 1.03-SEK 0.04 (-3.37%)
BrainCool AB (publ)’s quoted price sits in the upper half of its reported 52-week range, 10.26% below the high.
SEK 12.65-SEK 0.40 (-3.07%)
SciBase Holding AB (publ)’s quoted price sits in the lower half of its reported 52-week range, 76.57% below the high.
SEK 1.25SEK 0.00 (0.0%)
Iconovo AB (publ)’s quoted price sits in the lower half of its reported 52-week range, 31.69% below the high.
SEK 0.37+SEK 0.05 (+15.94%)
Biovica International AB (publ)’s quoted price sits in the lower half of its reported 52-week range, 39.18% below the high.
SEK 0.55+SEK 0.01 (+1.85%)
Neola Medical AB (publ)’s quoted price sits in the lower half of its reported 52-week range, 72.5% below the high.
SEK 0.17+SEK 0.00 (+1.49%)
Nanologica AB (publ)’s quoted price sits in the lower half of its reported 52-week range, 92.44% below the high.
SEK 7.61+SEK 0.01 (+0.13%)
Vivesto AB’s quoted price sits in the lower half of its reported 52-week range, 72.12% below the high.
SEK 0.49-SEK 0.00 (-0.4%)
Biosergen AB’s quoted price sits in the lower half of its reported 52-week range, 99.02% below the high.
